适应性免疫变化与阿尔茨海默病的临床进展有关
Lynn van Olst1,2,3, Alwin Kamermans4,5, Sem Halters4,5
1Department of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, the Netherlands. l.vanolst@northwestern.edu.
Molecular neurodegeneration
|April 24, 2024
概括
周围免疫细胞在阿尔茨海默病 (AD) 中发生变化. 在轻度认知障碍 (MCI) 中观察到特定的T细胞变化,与疾病生物标志物相关.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因.
- 在阿尔茨海默病中,外围免疫细胞的参与被建议,但不太了解.
研究的目的:
- 在AD患者中全面绘制外周免疫变化的地图.
- 为了比较轻度认知障碍 (MCI) 和痴呆阶段的免疫特征与对照.
主要方法:
- 通过飞行时间 (CyTOF) 利用细胞计量进行详细的免疫细胞分析.
- 分析了来自AD患者 (MCI/痴呆症) 和健康对照者的外周血液样本.
主要成果:
- 在AD中发现了适应性免疫特征.
- 在MCI中观察到特定T细胞 (PD1+ CD57+ CD8+ T效应记忆细胞重新表达CD45RA) 的积累.
- 发现免疫细胞子集,CSF生物标志物 (tau病理,神经退行,神经炎症) 和认知衰退之间的相关性.
- 记忆T/B细胞和ADCSF生物标志物之间发现了负面联系.
- 确定了APOE ε4等位基因对外周免疫力的影响.
结论:
- 显著的外周免疫变化发生在早期和晚期AD阶段.
- 需要进一步的研究,以了解这些免疫变化如何影响阿尔茨海默病的脑病理.
相关概念视频
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183


